School of Biological Sciences, University of Southamptongrid.5491.9, Southampton, United Kingdom.
School of Health Sciences, University of Southamptongrid.5491.9, Southampton, United Kingdom.
mBio. 2021 Oct 26;12(5):e0228121. doi: 10.1128/mBio.02281-21. Epub 2021 Sep 21.
Many of the most common disinfectant and sanitizer products are formulations of multiple antimicrobial compounds. Products claiming to contain synergistic formulations are common, although there is often little supporting evidence. The antimicrobial interactions of all pairwise combinations of common disinfectants (benzalkonium chloride, didecyldimethylammonium chloride, polyhexamethylene biguanide, chlorocresol, and bronopol) were classified via checkerboard assay and validated by time-kill analyses. Combinations were tested against Acinetobacter baumannii NCTC 12156, Enterococcus faecalis NCTC 13379, Klebsiella pneumoniae NCTC 13443, and Staphylococcus aureus NCTC 13143. Synergistic interactions were identified only for the combinations of chlorocresol with benzalkonium chloride and chlorocresol with polyhexamethylene biguanide. Synergism was not ubiquitously demonstrated against all species tested and was on the borderline of the synergism threshold. These data demonstrate that synergism between disinfectants is uncommon and circumstantial. Most of the antimicrobial interactions tested were characterized as additive. We suggest that this is due to the broad, nonspecific mechanisms associated with disinfectants not providing an opportunity for the combined activities of these compounds to exceed the sum of their parts. The scarcity of observed synergistic interactions suggests that in the case of many disinfectant-based products, combined mechanisms of interaction may be being misinterpreted. We emphasize the need to correctly differentiate between additivity and synergism in antimicrobial formulations, as inappropriate classification may lead to unnecessary issues in the event of regulatory changes. Furthermore, we question the need to focus on synergism and disregard additivity when considering combinations of disinfectants, as the benefits that synergistic interactions provide are not necessarily relevant to the application of the final product.
许多最常见的消毒剂和杀菌剂产品都是多种抗菌化合物的配方。声称含有协同配方的产品很常见,尽管通常几乎没有支持性证据。通过棋盘试验对所有常见消毒剂(苯扎氯铵、双癸基二甲基氯化铵、聚六亚甲基双胍、氯甲酚和溴硝醇)的所有成对组合的抗菌相互作用进行了分类,并通过时间杀灭分析进行了验证。组合测试了鲍曼不动杆菌 NCTC 12156、粪肠球菌 NCTC 13379、肺炎克雷伯菌 NCTC 13443 和金黄色葡萄球菌 NCTC 13143。仅发现氯甲酚与苯扎氯铵和氯甲酚与聚六亚甲基双胍的组合具有协同作用。协同作用并非在所有测试的物种中普遍存在,并且处于协同作用阈值的边缘。这些数据表明消毒剂之间的协同作用并不常见且情况特殊。测试的大多数抗菌相互作用均表现为相加作用。我们认为这是由于消毒剂与广泛的非特异性机制相关联,没有为这些化合物的联合活性提供超过其各自部分总和的机会。观察到的协同相互作用很少,这表明在许多基于消毒剂的产品的情况下,组合的相互作用机制可能被误解。我们强调需要正确区分抗菌配方中的相加作用和协同作用,因为不适当的分类可能会在监管变化的情况下导致不必要的问题。此外,我们质疑在考虑消毒剂组合时是否需要关注协同作用而忽略相加作用,因为协同相互作用提供的好处不一定与最终产品的应用相关。